Related Experiment Video
Updated: Jan 20, 2026

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
Published on: October 10, 2012
OPCML: A Promising Biomarker and Therapeutic Avenue
Isidora Simovic1, Natalia Castaño-Rodríguez1, Nadeem O Kaakoush2
1School of Biotechnology and Biomolecular Sciences, UNSW, Sydney, NSW 2052, Australia.
Abstract:
Opioid-binding protein/cell adhesion molecule (OPCML) is expressed in many tissues and localizes to the plasma membrane. It is a putative tumor suppressor that acts on receptor tyrosine kinases (RTKs), influencing cell cycle arrest, apoptosis, and migration. Its expression is silenced epigenetically in cancer, inferring potential diagnostic, prognostic, and therapeutic roles.
Insights
Opioid-binding protein/cell adhesion molecule (OPCML) functions as a tumor suppressor by regulating cell growth and migration. Its epigenetic silencing in cancer suggests roles in diagnosis, prognosis, and therapy.
Area of Science:
- Molecular biology
- Cell biology
- Cancer research
Background:
- Opioid-binding protein/cell adhesion molecule (OPCML) is a plasma membrane protein found in various tissues.
- OPCML is recognized as a potential tumor suppressor.
- It modulates receptor tyrosine kinases (RTKs), impacting cellular processes like apoptosis and migration.
Purpose of the Study:
- To investigate the role of OPCML in cancer.
- To explore the implications of OPCML's epigenetic silencing in tumorigenesis.
Main Methods:
- Analysis of OPCML expression patterns.
- Investigation of OPCML's functional interactions with RTKs.
- Evaluation of epigenetic silencing mechanisms affecting OPCML.
Main Results:
- OPCML expression is epigenetically silenced in cancerous tissues.
- OPCML's interaction with RTKs influences cell cycle arrest, apoptosis, and migration.
- Silencing of OPCML correlates with tumor development.
Conclusions:
- OPCML acts as a tumor suppressor through its regulation of RTK signaling pathways.
- Epigenetic silencing of OPCML is a significant event in cancer development.
- OPCML holds potential as a biomarker for cancer diagnosis and prognosis, and as a therapeutic target.
More Related Videos
06:39Author Spotlight: Design and Evaluation of Au-Electroplated Carbon Fiber Cloth Electrodes for Hydrogen Peroxide Fuel Cells
Published on: October 20, 2023
08:27Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
Related Concept Videos
Therapeutic Index
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Microorganisms in Medicine and Therapeutics
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...